DURASERT

Welcome to the Brand page for “DURASERT”, which is offered here for In the statement, line 4, through line 8, should be deleted, and injectable drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals via injection into the posterior chamber of the eye for the treatment of diseases and conditions, including ocular diseases, uveitis and retinal disease should be inserted. in the statement, line 10 is deleted, and injectable sustained drug delivery systems for delivering pharmaceuticals via injection into the posterior chamber of the eye is inserted.;injectable drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals via injection into the posterior chamber of the eye for the treatment of diseases and conditions, including ocular diseases, uveitis and retinal disease;injectable sustained drug delivery systems for delivering pharmaceuticals via injection into the posterior chamber of the eye;.

Its status is currently believed to be active. Its class is unavailable. “DURASERT” is believed to be currently owned by “EYEPOINT PHARMACEUTICALS US, INC.”